Inari Medical Inc (Inari) is a medical device company that develops, manufactures and commercializes innovative catheter-based technologies for treating venous thromboembolism (VTE). The company products portfolio includes the ClotTriever and FlowTriever systems, designed to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari products are used by healthcare professionals, including interventional radiologists, cardiologists and vascular surgeons, in catheterization laboratories and interventional suites. It operates in the US, Switzerland, Singapore, Canada, Australia, Brazil, the UK and Ireland. Inari is headquartered in Irvine, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Inari Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Inari Medical Inc Company Overview
- Inari Medical Inc Company Snapshot
- Inari Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Inari Medical Inc - Pipeline Analysis Overview
- Inari Medical Inc - Key Facts
- Inari Medical Inc - Major Products and Services
- Inari Medical Inc Pipeline Products by Development Stage
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
- Inari Medical Inc Pipeline Products Overview
- ClotTriever Thrombectomy System
- ClotTriever Thrombectomy System Product Overview
- ClotTriever Thrombectomy System Clinical Trial
- Crossing Device
- Crossing Device Product Overview
- FlowSaver Blood Return System
- FlowSaver Blood Return System Product Overview
- FlowTriever Catheter
- FlowTriever Catheter Product Overview
- FlowTriever Catheter Clinical Trial
- FlowTriever2 Catheter
- FlowTriever2 Catheter Product Overview
- FlowTriever2 Catheter - Pulmonary Embolism
- FlowTriever2 Catheter - Pulmonary Embolism Product Overview
- FlowTriever2 Catheter - Pulmonary Embolism Clinical Trial
- LimFlow Percutaneous Deep Vein Arterialisation System
- LimFlow Percutaneous Deep Vein Arterialisation System Product Overview
- LimFlow Percutaneous Deep Vein Arterialisation System Clinical Trial
- Recanalization Device
- Recanalization Device Product Overview
- Stent Cleaner Device
- Stent Cleaner Device Product Overview
- Triever16 Curve
- Triever16 Curve Product Overview
- Triever20
- Triever20 Product Overview
- Triever20 Clinical Trial
- Triever24
- Triever24 Product Overview
- Triever24 Flex Catheter
- Triever24 Flex Catheter Product Overview
- Inari Medical Inc - Key Competitors
- Inari Medical Inc - Key Employees
- Inari Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Inari Medical Inc, Recent Developments
- Mar 12, 2024: Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
- Feb 14, 2024: Inari Medical Receives FDA 510(k) Clearance For VenaCore Thrombectomy Catheter (46-101)
- Jan 05, 2024: Inari Medical Receives FDA 510(k) Clearance for ClotTriever13 Gen 3 Sheath
- Nov 28, 2023: Inari Medical enrols first patient in FlowTriever System trial
- Oct 31, 2023: First Round of Late-Breaking Clinical Trial Results Announced at VIVA23
- Oct 02, 2023: LimFlow Obtains Pre-Market Approval (PMA) for LimFlow System
- Sep 12, 2023: FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
- Aug 01, 2023: Inari Medical Receives Additional 510(k) Clearance for Triever20 Curve
- Jul 25, 2023: Inari Medical Receives Additional 510(K) Clearance for FlowSaver Blood Return System
- Jun 07, 2023: Inari Medical Announces Commercial Launch of RevCore and Triever16 Curve, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Inari Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Inari Medical Inc Pipeline Products by Equipment Type
- Inari Medical Inc Pipeline Products by Indication
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
- Inari Medical Inc, Key Facts
- Inari Medical Inc, Major Products and Services
- Inari Medical Inc Number of Pipeline Products by Development Stage
- Inari Medical Inc Pipeline Products Summary by Development Stage
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
- Inari Medical Inc Ongoing Clinical Trials Summary
- ClotTriever Thrombectomy System - Product Status
- ClotTriever Thrombectomy System - Product Description
- ClotTriever Thrombectomy System - DEFIANCE - ClotTriever Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis
- Crossing Device - Product Status
- Crossing Device - Product Description
- FlowSaver Blood Return System - Product Status
- FlowSaver Blood Return System - Product Description
- FlowTriever Catheter - Product Status
- FlowTriever Catheter - Product Description
- FlowTriever Catheter - Large-bore Mechanical Thrombectomy for the Treatment of Symptomatic Portomesenteric Vein Thrombosis
- FlowTriever Catheter - Outcomes of Mechanical Thrombectomy with the FlowTriever Device in Acute Pulmonary Embolism, Results of a Swedish Retrospective Analysis
- FlowTriever Catheter - Percutaneous Embolectomy, Ultrasund Assisted Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
- FlowTriever Catheter - Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever: Efficacy and Safety
- FlowTriever2 Catheter - Product Status
- FlowTriever2 Catheter - Product Description
- FlowTriever2 Catheter - Pulmonary Embolism - Product Status
- FlowTriever2 Catheter - Pulmonary Embolism - Product Description
- FlowTriever2 Catheter - Pulmonary Embolism - FlowTriever Pulmonary Embolectomy Clinical Study - FlowTriever2
- FlowTriever2 Catheter - Pulmonary Embolism - PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism
- LimFlow Percutaneous Deep Vein Arterialisation System - Product Status
- LimFlow Percutaneous Deep Vein Arterialisation System - Product Description
- LimFlow Percutaneous Deep Vein Arterialisation System - Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization for the Treatment of Late-stage Chronic Limb-threatening Ischemia: The PROMISE II Trial
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
- Recanalization Device - Product Status
- Recanalization Device - Product Description
- Stent Cleaner Device - Product Status
- Stent Cleaner Device - Product Description
- Triever16 Curve - Product Status
- Triever16 Curve - Product Description
- Triever20 - Product Status
- Triever20 - Product Description
- Triever20 - FlowTriever All-comer Registry for Patient Safety and Hemodynamics: FLASH
- Triever24 - Product Status
- Triever24 - Product Description
- Triever24 Flex Catheter - Product Status
- Triever24 Flex Catheter - Product Description
- Inari Medical Inc, Key Employees
- Inari Medical Inc, Subsidiaries
- Glossary
- Inari Medical Inc Pipeline Products by Equipment Type
- Inari Medical Inc Pipeline Products by Development Stage
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Penumbra Inc
- Abbott Laboratories
- Philips North America LLC
- Teleflex Inc
- AngioDynamics Inc
- Boston Scientific Corp
